Chemours Files 8-K for Financial Statements and Exhibits
Ticker: CC · Form: 8-K · Filed: Mar 29, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Mar 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financials
Related Tickers: CC
TL;DR
Chemours filed a routine 8-K for financial statements. No major news.
AI Summary
On March 28, 2024, The Chemours Company filed an 8-K to disclose information regarding its financial statements and exhibits. This filing is a routine update and does not appear to contain any material new financial information or significant corporate events.
Why It Matters
This filing serves as a standard disclosure for The Chemours Company, providing the SEC with updated financial statements and exhibits as required by regulations.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not indicate any new risks or material changes.
Key Players & Entities
- The Chemours Company (company) — Registrant
- Delaware (location) — State of Incorporation
- March 28, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by The Chemours Company?
The primary purpose of this 8-K filing is to disclose information regarding its financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Financial Statements and Exhibits' section.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is March 28, 2024, as stated under 'Date of Earliest Event Reported'.
In which state is The Chemours Company incorporated?
The Chemours Company is incorporated in Delaware, as indicated by 'State or Other Jurisdiction of Incorporation: Delaware'.
What is the principal executive office address for The Chemours Company?
The address of the principal executive offices for The Chemours Company is 1007 Market Street, Wilmington, Delaware 19801.
What is the SEC file number for The Chemours Company?
The SEC file number for The Chemours Company is 001-36794.
Filing Stats: 491 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-03-28 20:18:00
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
Filing Documents
- d814209d8k.htm (8-K) — 24KB
- d814209dex991.htm (EX-99.1) — 80KB
- 0001193125-24-081149.txt ( ) — 247KB
- cc-20240328.xsd (EX-101.SCH) — 3KB
- cc-20240328_lab.xml (EX-101.LAB) — 17KB
- cc-20240328_pre.xml (EX-101.PRE) — 11KB
- d814209d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Transcript of conference call held on March 28, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY Date: March 29, 2024 By: /s/ Matthew S. Abbott Name: Matthew S. Abbott Title: Interim Chief Financial Officer